Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model
PURPOSEUse of oral sorafenib, an antiangiogenic chemotherapeutic agent for hepatocellular carcinoma (HCC), is limited by an unfavorable side effect profile. Transarterial chemoembolization (TACE) employs targeted intravascular drug administration, and has potential as a novel sorafenib delivery meth...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-05-01
|
Series: | Diagnostic and Interventional Radiology |
Online Access: |
http://www.dirjournal.org/archives/archive-detail/article-preview/pharmacokinetic-study-of-conventional-sorafenib-ch/55820
|